Novo Nordisk | Betriebsaufwand

Operating Expenses Veränderung Datum
ANI Pharmaceuticals USD 122.38M 2.55M 2024-03
Aurora Cannabis CAD 90.99M 24.97M 2023-12
Bausch Health Companies USD 1.86B 186M 2024-03
Bristol-Myers Squibb USD 10.35B 728M 2024-03
Canopy Growth CAD 105.6M 33.79M 2024-03
Catalent USD 1.09B 45M 2024-03
Corcept Therapeutics USD 117.31M 13.57M 2024-03
Drreddys Laboratories INR 54.88B 3.95B 2023-12
Eli Lilly USD 6.03B 933.2M 2024-03
GlaxoSmithKline GBP 5.87B 1.61B 2024-03
Merck USD 10.02B 6.55B 2024-03
Novartis USD 8.75B 447M 2024-03
Novo Nordisk DKK 33.5B 5.59B 2024-03
Pacira USD 152M 3.93M 2024-03
Perrigo USD 1.09B 76.3M 2024-03
Prestige Brands USD 194.84M 1.07M 2024-03
Sanofi EUR 8.89B 600M 2024-03
Supernus Pharmaceuticals USD 147.89M 17.42M 2024-03
Zoetis USD 1.39B 174M 2024-03



Novo Nordisk Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jun 2024.